AVAIOTCServices-Computer Processing & Data PreparationFiscal year ends March 31
AVAI BIO, INC.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.11−0.00 (-1.75%)
Close on Oct 19, 2026
- Market cap
- $17.24M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.2082 (−65.02%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $17.24M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$2.79M
- EPS, diluted
- $0.00
- Book value per share
- -$0.02
- Diluted shares
- 154M
Nine years at a glance
Fiscal years 2018 to 2026 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$1.81M
Net income
-$2.79M
EPS, diluted
$0.00
Reported periodTrailing twelve months